DaVita Stock (NYSE:DVA)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$141.59

52W Range

$78.05 - $168.50

50D Avg

$157.78

200D Avg

$139.80

Market Cap

$11.89B

Avg Vol (3M)

$790.94K

Beta

0.87

Div Yield

-

DVA Company Profile


DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Show More

Industry

Medical - Care Facilities

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

70,000

IPO Date

Oct 31, 1995

Website

DVA Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
U S Dialysis And Related Lab Services$10.94B$10.51B$10.58B
Other Segments$1.30B$1.10B$1.04B

Fiscal year ends in Dec 23 | Currency in USD

DVA Financial Summary


Dec 23Dec 22Dec 21
Revenue$12.14B$11.61B$11.62B
Operating Income$1.60B$1.34B$1.80B
Net Income$691.53M$768.19M$978.45M
EBITDA$2.35B$2.06B$2.48B
Basic EPS$7.62$8.02$9.30
Diluted EPS$7.42$8.02$8.90

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Oct 29, 24 | 9:27 PM
Q2 24Aug 06, 24 | 8:19 PM
Q1 24May 02, 24 | 12:00 AM

Peer Comparison


TickerCompany
HCAHCA Healthcare, Inc.
AMEDAmedisys, Inc.
OPCHOption Care Health, Inc.
AMNAMN Healthcare Services, Inc.
SGRYSurgery Partners, Inc.
USPHU.S. Physical Therapy, Inc.
EHCEncompass Health Corporation
UHSUniversal Health Services, Inc.
ACHCAcadia Healthcare Company, Inc.
ENSGThe Ensign Group, Inc.
THCTenet Healthcare Corporation
CYHCommunity Health Systems, Inc.